Join the club for FREE to access the whole archive and other member benefits.

New immunotherapy clears out senescent cells to combat aging

Activated immune cells can treat age-related chronic diseases - a potential alternative to senolytics

10-May-2021

Key points from article :

Scientists are learning how immune cells clear senescent cells that contribute to aging and chronic diseases.

In a healthy state, invariant Natural Killer T (iNKT) cells eliminate cells the body senses as foreign, including senescent cells.

The iNKT cells become less active with age and other factors like obesity.

Finding ways to stimulate this natural surveillance system offers an alternative to senolytic therapies.

"Using iNKT-targeted therapy can piggyback on their exquisite, built-in specificity," said Anil Bhushan, senior author.

Could remove senescent cells by using lipid antigens to activate iNKT cells.

When treated mice with diet-induced obesity, their blood glucose levels improved, while mice with lung fibrosis had fewer damaged cells, and also lived longer.

"This is a potential immune therapy for senescence and fibrosis," - Mallar Bhattacharya, co-author.

"...activating iNKT cells could be used to treat a wide variety of diseases," - Bhushan.

Study by UCSF published in Cell Press: Med.

Mentioned in this article:

Click on resource name for more details.

Anil Bhushan

Professor at UCSF and co-founder of Deciduous Therapeutics.

Cell Press

Publisher of biomedical journals including Cell, Neuron and many others

Mallar Bhattacharya

Associate Professor in the Division of Pulmonary and Critical Care at UCSF

University of California, San Francisco (UCSF)

Public research university that is part of the University of California system and dedicated entirely to health science

Topics mentioned on this page:
Senescent Cells, Immunosenescence